J&J warns over pump safety; Researchers say their bot beats Intuitive's;

@FierceMedDev: Special Report: Top 10 Med Tech Investments of Q2. Feature | Follow @FierceMedDev

@MarkHFierce: U.K. researchers believe that low levels of a specific protein can signify aggressive colorectal cancer. More | Follow @MarkHFierce

@DamianFierce: Fresh deals and booming sales have Illumina brightening its 2013 guidance. News | Follow @DamianFierce

> Johnson & Johnson's ($JNJ) Codman unit has issued a safety warning on its MedStream infusion pump, and the FDA has assigned its most serious label to the problem. Note

> Qiagen ($QGEN) and Exosome Diagnostics have teamed up to develop and sell sample preparation kits for nucleic acid analysis. News

> Tokyo Institute of Technology scientists have developed a surgical robot they say would cost between a third and a 10th of Intuitive Surgical's ($ISRG) da Vinci system, but their prototype is at least 5 years away from clinical use. Article

> Cancer Genetics ($CGIX) has launched a new cervical cancer test, designed to screen women with HPV-positive abnormal cervical lesions. More

> Co-Diagnostics and DNA Logix have formed a joint venture to develop infectious disease tests for the developing world. Story

> Life Technologies ($LIFE) has expanded its diagnostics platform offerings, launching two new PCR systems. Item

> Hologic ($HOLX) won FDA approval to pair its Aptima HPV assay with the fully automated Panther diagnostic system. Release

Biotech News

@FierceBiotech: PR: Verastem receives orphan drug designation from the FDA for defactinib in mesothelioma. Release | Follow @FierceBiotech

@RyanMFierce: Roche highlights more upbeat PhIII data for 'breakthrough' leukemia contender. News | Follow @RyanMFierce

@EmilyMFierce: Scientists advocate for more responsible preclinical studies. Item | Follow @EmilyMFierce

> Merck advances cardio drug under FDA review. More

> Big Pharma agrees to widen access to clinical trial data. Story

> After FDA meeting, Sarepta plans fast filing for DMD drug eteplirsen. Report

Pharma News

@FiercePharma: Lilly sales up 6%, to $5.93B; Cymbalta up 22% (!). Too bad it gets generic rivals later this year. Release | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Special report on the projected top 20 orphan drugs of 2018... see who made the list. Feature | Follow @CarlyHFierce

> GlaxoSmithKline sales tick up, but China probe will hit growth. Story

> GlaxoSmithKline CEO says HQ, British execs 'knew nothing' of China fraud. Report

Biomarkers News

> Epigenetic tags point to a new generation of age-related biomarkers. Report

> Nerves could predict aggressiveness of prostate cancer. More

> Takeda and Zinfandel advance Alzheimer's biomarker work. Story

> Plaque buildup trajectory may serve as a clue for Alzheimer's. Article

> Autism clues: UC Davis team spots two new potential biomarkers of the condition. Item

Drug Delivery News

 @MichaelGFierce: Regulus completes $49M public offering to support microRNA tech. Report | Follow @MichaelGFierce

> Novaliq secures CE mark for OTC drop to treat dry eye. News

> Supercomputer-designed hypertension drug mimics natural hormone response. Story

> Imprimis to begin osteoarthritis cream PhIII, snags transdermal wound treatment. More

> Cancer drug breaches blood-brain barrier using nanovesicles. Article

> Flowonix reports longest service life ever in 6-year Prometra trial. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.